Bachmann 1 1 Vanderbilt University Medical Center, Nashville, Tennessee, USA, 2 Duke University Medical Center, Durham, North Carolina, USA, 3 Washington University School of Medicine, St
the FDA's 2026 enforcement is squarely aimed here
T2D patients with severe renal impairment are not eligible for SGLT2 inhibitors, and GLP-1RAs could be an important therapeutic option for these patients
For those receiving retatrutide outside a trial setting (for example, via named-patient supply), contact your dispensing pharmacist or prescribing clinician promptly
Researchers studying -arrestin recruitment, internalisation kinetics, and biased signalling commonly include tirzepatide as a positive control alongside native GIP, native GLP-1, and selective single-receptor agonists such as semaglutide or exenatide
A couple telling quotes from higher-ups at the company: We started re-embracing Weight Watchers because I think its important to not shy away from the conversation around weight loss being important for health outcomes. And another: We have no interest in prescribing medications to those who are trying to lose 10 pounds for a reunion. Still: GLP-1s are not a miracle cure